Cancer Research and Treatment

The impact of radiation dose on the efficacy of definitive chemoradiotherapy in patients with locally advanced esophageal carcinoma: a systematic review and meta-analysis

High-Dose Versus Standard-Dose Intensity-Modulated Radiotherapy With Concurrent Paclitaxel Plus Carboplatin for Patients With Thoracic Esophageal Squamous Cell Carcinoma: A Randomized, Multicenter, Open-Label, Phase 3 Superiority Trial

Jing You, Shuchai Zhu, Jiancheng Li, Jie Li, Junyue Shen, Yidian Zhao, Xiaomin Li, Lin Jia, Qingshan Li, Jun Yang, Yiqun Wu, Wenbin Shen, Haishan Wu, Xueqin Wu, Xiaomin Wang, Yaqiong Ren, Jun He, Pingping Lin, Guangying Zhu, Anhui Shi

International Journal of Radiation Oncology*Biology*Physics.2023; 115(5): 1129. CrossRef

Intensity-modulated radiotherapy with more than 60 Gy improved the survival of inoperable patients with locally advanced esophageal squamous cell carcinoma

Wei Zhang, Qing Xie, Bifa Zhu, Xiaokang Wang, Ling He, Yong Zhang

A Phase III Multicenter Randomized Clinical Trial of 60 Gy versus 50 Gy Radiation Dose in Concurrent Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma

Yujin Xu, Baiqiang Dong, Weiguo Zhu, Jiancheng Li, Rong Huang, Zongwen Sun, Xinmei Yang, Liping Liu, Han He, Zhongxing Liao, Ni Guan, Yue Kong, Wanwei Wang, Jianxiang Chen, Huijuan He, Guoqin Qiu, Ming Zeng, Juan Pu, Wangyuan Hu, Yong Bao, Zhigang Liu, Ju

Clinical Cancer Research.2022; 28(9): 1792. CrossRef

Comparative clinical studies of primary chemoradiotherapy versus S-1 and nedaplatin chemotherapy against stage IVb oesophageal squamous cell carcinoma: a multicentre open-label randomised controlled trial

Yun Liu, Narasimha M Beeraka, Junqi Liu, Kuo Chen, Bo Song, Zhang Song, Jianchao Luo, Yang Liu, Anping Zheng, Yanhui Cui, Yang Wang, Zhenhe Jia, Xiangyu Song, Xiaohong Wang, Hongqi Wang, Xuefeng Qi, Jinshan Ren, Liping Wu, Jixing Cai, Xainying Fang, Xin W

A Novel Model Combining Tumor Length, Tumor Thickness, TNM_Stage, Nutritional Index, and Inflammatory Index Might Be Superior to the 8th TNM Staging Criteria in Predicting the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated With Definitiv

Xiaohui Chen, Yilin Yu, Haishan Wu, Jianjian Qiu, Dongmei Ke, Yahua Wu, Mingqiang Lin, Tianxiu Liu, Qunhao Zheng, Hongying Zheng, Jun Yang, Zhiping Wang, Hui Li, Lingyun Liu, Qiwei Yao, Jiancheng Li, Wenfang Cheng

Comparison of involved-field intensity-modulated radiotherapy combined with S-1 vs radiotherapy alone for elderly patients with esophageal cancer

Li-Hua Liu, Mao-Hui Yan, Yu-Peng Di, Zhi-Guang Fu, Xiao-Dan Zhang, Hong-Qi Li

World Journal of Clinical Cases.2022; 10(21): 7365. CrossRef

A combined predicting model for benign esophageal stenosis after simultaneous integrated boost in esophageal squamous cell carcinoma patients (GASTO1072)

Weitong Liu, Chengbing Zeng, Siyan Wang, Yizhou Zhan, Ruihong Huang, Ting Luo, Guobo Peng, Yanxuan Wu, Zihan Qiu, Derui Li, Fangcai Wu, Chuangzhen Chen

Definitive chemoradiotherapy for clinical T4b esophageal cancer – Treatment outcomes, failure patterns, and prognostic factors

Tzu-Ting Huang, Shau-Hsuan Li, Yen-Hao Chen, Hung-I Lu, Chien-Ming Lo, Fu-Min Fang, Shang-Yu Chou, Yi-Chun Chiu, Yeh-Pin Chou, Yu-Ming Wang

Radiotherapy and Oncology.2021; 157: 56. CrossRef

Feasibility and Oncological Outcome of Preoperative Chemoradiation With IMRT Dose Intensification for Locally Advanced Esophageal and Gastroesophageal Cancer

Roberto Innocente, Federico Navarria, Roberto Petri, Elisa Palazzari, Massimo Vecchiato, Jerry Polesel, Antonio Ziccarelli, Antonio Martino, Paolo Ubiali, Dino Tonin, Andrea Lauretta, Claudio Belluco, Luisa Foltran, Angela Buonadonna, Arben Lleshi, Carlot

K. Jingu, R. Umezawa, T. Yamamoto, Y. Ishikawa, N. Takahashi, K. Takeda, Y. Suzuki, S. Teramura, S. Omata

Nihon Kikan Shokudoka Gakkai Kaiho.2021; 72(2): 84. CrossRef

Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study)

Maarten C. C. M. Hulshof, Elisabeth D. Geijsen, Tom Rozema, Vera Oppedijk, Jeroen Buijsen, Karen J. Neelis, Joost J. M. E. Nuyttens, Maurice J. C. van der Sangen, Paul M. Jeene, Jannie G. Reinders, Mark I. van Berge Henegouwen, Adriana Thano, Jeanin E. va

Journal of Clinical Oncology.2021; 39(25): 2816. CrossRef

Esophageal Cancer Radiotherapy Dose Escalation Meta Regression Commentary: “High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis”

Ronald Chow, Michael Lock, Sangjune Laurence Lee, Simon S. Lo, Charles B. Simone

Phase II Trial of Epigallocatechin-3-Gallate in Acute Radiation-Induced Esophagitis for Esophagus Cancer

Xiaoling Li, Ligang Xing, Yujun Zhang, Peng Xie, Wanqi Zhu, Xiangjiao Meng, Yinxia Wang, Lingling Kong, Hanxi Zhao, Jinming Yu

Journal of Medicinal Food.2020; 23(1): 43. CrossRef

Intensity-Modulated Radiotherapy versus Three-Dimensional Conformal Radiotherapy in Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: Comparison of Survival Outcomes and Toxicities

Nai-Bin Chen, Bo Qiu, Jun Zhang, Meng-Yun Qiang, Yu-Jia Zhu, Bin Wang, Jin-Yu Guo, Ling-Zhi Cai, Shao-Min Huang, Meng-Zhong Liu, Qun Li, Yong-Hong Hu, Qi-Wen Li, Hui Liu

Cancer Research and Treatment.2020; 52(1): 31. CrossRef

High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis

Xin Sun, Lei Wang, Yang Wang, Jingjing Kang, Wei Jiang, Yu Men, Zhouguang Hui

Stage III Esophageal Squamous Cell Carcinoma Patients With Three-Dimensional Conformal or Intensity-Modulated Radiotherapy: A Multicenter Retrospective Study

Qin Qin, Xiaolin Ge, Xin Wang, Lan Wang, Chen Li, Junqiang Chen, Xiaomin Wang, Yidian Zhao, Wencheng Zhang, Ping Wang, Qingsong Pang, Kaixian Zhang, Ling Li, Miaomiao Hu, Chongli Hao, Gaofeng Li, Yonggang Xu, Xueying Qiao, Zhiguo Zhou, Shuchai Zhu, Wenbin

Relationship Between Sarcopenia and Prognosis in Patient With Concurrent Chemo-Radiation Therapy for Esophageal Cancer

Dae Won Ma, Yeona Cho, Mi-jin Jeon, Jie-Hyun Kim, Ik Jae Lee, Young Hoon Youn, Jae Jun Park, Da Hyun Jung, Hyojin Park, Chang Geol Lee, Jun Won Kim, Hei Cheul Jeung

Different prognosis of patients with esophageal carcinoma with M1a and regional node involvement

Tae Ryong Chung, Jie-Hyun Kim, Ik Jae Lee, Yeona Cho, Jun Won Kim, Chang Geol Lee, Da Hyun Jung, Jae Jun Park, Young Hoon Youn, Hyojin Park

Digestive and Liver Disease.2019; 51(11): 1610. CrossRef

Effect of modern high-dose versus standard-dose radiation in definitive concurrent chemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis

Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer

Dawei Chen, Hari Menon, Vivek Verma, Steven N. Seyedin, Jaffer A. Ajani, Wayne L. Hofstetter, Quynh-Nhu Nguyen, Joe Y. Chang, Daniel R. Gomez, Arya Amini, Stephen G. Swisher, Mariela A. Blum, Ahmed I. Younes, Hampartsoum B. Barsoumian, Jeremy J. Erasmus,

Prognostic value of tumor length and diameter for esophageal squamous cell cancer patients treated with definitive (chemo)radiotherapy: Potential indicators for nonsurgical T staging

Hongyao Xu, Shengxi Wu, Hesan Luo, Chuyun Chen, Lianxing Lin, Hecheng Huang, Renliang Xue

Prognostic impact of postoperative pulmonary complications following salvage esophagectomy after definitive chemoradiotherapy

Masaru Hayami, Masayuki Watanabe, Naoki Ishizuka, Shinji Mine, Yu Imamura, Akihiko Okamura, Takanori Kurogochi, Kotaro Yamashita

Journal of Surgical Oncology.2018; 117(6): 1251. CrossRef

Definite intensity‐modulated radiotherapy with concurrent chemotherapy more than 4 cycles improved survival for patients with locally‐advanced or inoperable esophageal squamous cell carcinoma

He‐Yuan Hsieh, Chung‐Ping Hsu, Hui‐Ling Yeh, Cheng‐Yen Chuang, Jai‐Fu Lin, Chen‐Fa Chang

The Kaohsiung Journal of Medical Sciences.2018; 34(5): 281. CrossRef

Comparison of definite chemoradiation therapy with carboplatin/paclitaxel or cisplatin/5-fluoruracil in patients with squamous cell carcinoma of the esophagus

Stefan Münch, Steffi U. Pigorsch, Michal Devečka, Hendrik Dapper, Wilko Weichert, Helmut Friess, Rickmer Braren, Stephanie E. Combs, Daniel Habermehl

Definitive radiotherapy dose escalation with chemotherapy for treating non-metastatic oesophageal cancer

Chao-Yueh Fan, Yu-Fu Su, Wen-Yen Huang, Hsing-Lung Chao, Kuen-Tze Lin, Chun-Shu Lin

The role of definitive chemoradiation in patients with non-metastatic oesophageal cancer

Paul M. Jeene, Hanneke W.M. van Laarhoven, Maarten C.C.M. Hulshof

Best Practice & Research Clinical Gastroenterology.2018; 36-37: 53. CrossRef

High‐dose versus standard‐dose radiation therapy for cervical esophageal cancer: A retrospective single‐institution study

Tae Hyung Kim, Ik Jae Lee, Ji‐Hyun Kim, Chang Geol Lee, Yong Chan Lee, Jun Won Kim

Nedaplatin‑based chemotherapy regimens combined with concurrent radiotherapy as first‑line treatment for stage II‑III esophageal squamous cell carcinoma

Huiping Zhu, Xiaolin Ge, Yufeng Lu, Yun Zuo, Qin Qin, Xinchen Sun, Min Yang

Improved survival with higher radiation dose for esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy